BlueRock Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
BlueRock Therapeutics is a regenerative medicine company founded in 2016, focusing on stem cell technology to develop cell therapies for cardiovascular, neurodegenerative, and immunological diseases. It operates as a wholly owned subsidiary of Bayer AG since 2019 and was launched with significant financial backing, including a $225 million Series A financing.
The company utilizes its proprietary CELL+GENE™ platform, which employs induced pluripotent stem cells (iPSCs) to create authentic cell types for therapeutic use. This technology allows for the production of patient-matched or allogeneic cell therapies while avoiding ethical concerns associated with embryonic stem cells. Its research and development hubs are located in Toronto, New York City, and Cambridge, Massachusetts. The organization collaborates with leading academic and industrial partners to advance its product pipeline, focusing on therapies for neurodegenerative diseases like Parkinson's disease, cardiomyocyte-based treatments for heart failure, and immune cell therapies for immune-related conditions.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxx | $5346 | 27 | Private | - | 6191 | xxxx |
| xx | $84951 | 145 | Private | - | 8157 | xxxxxx |
| xxxxxxxxx | $44949 | 108 | Private | - | 3075 | xxxxxxx |
| xxxxxxx | $54440 | 102 | Private | - | 1867 | xxx |
| x | $40153 | 93 | Private | - | 3987 | xxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.